Monday, March 24, 2014

Global generic drugs market to reach $518.5 billion by 2018

This is a time of growth and change for the generic pharmaceutical sector. With several blockbuster brands coming off patent, demand for generic replacements is increasing steadily, resulting in reduced profit margins and an intense M&A environment. Indeed, the rise of so-called super-generics and mounting pressures to reduce healthcare costs globally are pushing drug prices even lower. Further, a whole new market field -- biogenerics -- is opening up, for those generics companies prepared to buy in. However, not all traditional companies are well-suited for these conditions.

BCC Research provides an in-depth analysis of the global market for generic drugs through its report Global Markets for Generic Drugs. According to the report, this market was valued at nearly $270 billion in 2012 and is estimated at nearly $301 billion for 2013. BCC Research projects the market to grow to $518.5 billion by 2018, and register a five-year compound annual growth rate of 11.5% from 2013 to 2018.

RSS Feeds – Pharmaceuticals
Use this report to:
  • Gain an overview of the global market for generic drugs, including coverage of therapeutics such as antibacterials, antidepressants, anticancer agents, anti-arthritics, cardiovascular drugs, and drugs for respiratory conditions.
  • Analyze global market trends, with data from 2012, estimates for 2013, and projections of CAGRs through 2018.
  • Examine strategies employed by companies specializing in generics to meet the challenges of this highly competitive market, while also summarizing strategies employed by “originator” companies to forestall generic competition.
  • Assess important trends by product categories and major country markets, acknowledging that Brazil, China, India, Mexico, and Russia are among the rising markets for generic activity.
  • Review comprehensive company profiles of major players in the industry.

To order your copy of this report (or any of its chapters) or to download the complimentary introduction chapter, click here.

No comments:

Post a Comment

Bookmark and Share